Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.


Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013



All Upcoming Events
1 2 Next 
The 9th Annual Bioprocessing Summit21 Aug 2017
2nd International Conference on Generic Drugs and Biosimilars24 Aug 2017
14th International Conference and Exhibition on Pharmaceutical Formulations28 Aug 2017
13th Compound & Sample Management Summit28 Aug 2017
15th International Conference on Environmental Science and Technology (CEST 2017)31 Aug 2017
2nd European Prefilled Syringes Summit6 Sep 2017
World Congress on Biotherapeutics and Bioanalytical Techniques11 Sep 2017
4th International Conferences on Clinical Trails11 Sep 2017
Drug Safety Congress Europe 201712 Sep 2017
6th International Conference on Forensic Research & Technology18 Sep 2017
Phacilitate Cell & Gene Therapy Europe 201719 Sep 2017
Microbiome AgBioTech Summit 201720 Sep 2017
3rd Conference on Innovations to Advanced Clinical Research and Clinical Trials20 Sep 2017
9th Annual Pharmaceutical Analysis Conference25 Sep 2017
14th Confocal Raman Imaging Symposium25 Sep 2017
Biosimilars & Biobetters 201727 Sep 2017
6th Annual Cancer Vaccines Conference27 Sep 2017
ELRIG: Drug Discovery 20173 Oct 2017
Drug Discovery 20173 Oct 2017
7th Annual EPP Life Science Pricing Forum4 Oct 2017
3rd Drug Discovery Innovation Programme5 Oct 2017
Lab Asia 201710 Oct 2017
The 17th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2017)10 Oct 2017
Pharmaceutical Pricing and Market Access 201711 Oct 2017
4th International Conference on Past and Present Research Systems of Green Chemistry16 Oct 2017
11th World Drug Delivery Summit16 Oct 2017
Next-Generation Antibodies and Protein Analysis (2nd Edition)16 Oct 2017
6th Global Congress on Mass Spectrometry (Mass Spectra 2017)18 Oct 2017
7th Annual Orphan Drugs and Rare Diseases UK18 Oct 2017
Pain Medicine 201719 Oct 2017

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement